← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Natl Centre/Hiv Epidemiology/Clncl Res
Sydney
$2,127,727
Total funding
2
Grants
Funding mix
By agency
NIH$2,127,727 · 2
By mechanism
R01$2,127,727 · 2
Investigators at Natl Centre/Hiv Epidemiology/Clncl Res
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Longitudinal cohort of newly acquired HCV infection$389,499
R01 · FY2005 · DA
Longitudinal cohort of newly acquired HCV infection$384,435
R01 · FY2004 · DA
Longitudinal cohort of newly acquired HCV infection$353,793
R01 · FY2003 · DA
PROTEASE INHIBITOR RELATED ATHEROSCLEROSIS IN HIV$200,000
R01 · FY2000 · HL
PROTEASE INHIBITOR RELATED ATHEROSCLEROSIS IN HIV$200,000
R01 · FY2001 · HL
PROTEASE INHIBITOR RELATED ATHEROSCLEROSIS IN HIV$200,000
R01 · FY2004 · HL
PROTEASE INHIBITOR RELATED ATHEROSCLEROSIS IN HIV$200,000
R01 · FY2005 · HL
PROTEASE INHIBITOR RELATED ATHEROSCLEROSIS IN HIV$200,000
R01 · FY2003 · HL